1. Cathie IAB. Apparent idiopathic Heinz body anae­mia. Great Ormond Str J 1952; 3: 43-47.

2. Steadman JH, Yates A, Huehns ER. Idiopathic Heinz body anaemia: Hb Bristol (b67(E11) Val®Asp). Br J Haematol 1970; 18: 435-446.

3. Carrell RW, Lehmann H, Hutchison HE. Haemo­globin Koln (b-98 valine®methionine): an unstable pro­tein causing inclusion-body anaemia. Nature 1966; 210: 915-916.

4. Dacie JV, Shinton NK, Gaffney PJ Jr, Lehmann H. Haemoglobin Hammersmith (b-42 (CD1) Phe®Ser). Na­ture 1967; 216: 663-665.

5. Huisman THJ, Carver MFH, Efremov GD. A Sylla­bus of Human Hemoglobin Variants (Second Edition). The Sickle Cell Anemia Foundation, Augusta, GA, USA, 1998.

6. Ricco G, Ravazzolo R, Rege-Cambrin G, Capaldi A, Trento M, Lecchi M, Sartori ML, Furlani C, Rietto GB, Rabino-Massa E. Koln haemoglobinopathy in Italy. Panminerva Med 1981; 23: 227-233.

7. Indrak K, Brabec V, Wilson JB, Webber BB, Huisman THJ. Hb Koln or a₂b₂(98)(FG5)Val® Met in a Czechoslovakian family. Hemoglobin 1991; 15(1&2): 133-135.

8. Landin B, Frostad B, Brune M, Ljung R. Haemo­globin Koln as de novo mutations in Sweden: diagnosis by PCR and specific enzymatic cleavage. Eur J Haematol 1994; 52: 156-161.

9. Chang YH, Hur M, Lee DS, Park SS, Kim BK, Park S, Ohba Y, Hattori Y, Cho HI. The first case of Hb Koln [b98(FG5)Val®Met] in Korea. Hemoglobin 1999; 23(3): 287-289.

10. Chang J-G, Yang T-Y, Perng L-I, Wang J-C, Tsan K-W. Hb Koln [b98(FG5)Val®Met]: the first case found in a Chinese family. Hemoglobin 1998; 22(5&6): 535-536.

11. Gurgey A, Altay C. Hemoglobin Koln [b98(FG5) Val®Met] in a Turkish child. Turk J Pediatr 1982; 24: 271-273.

12. Galacteros F, Loukopoulos D, Fessas P, Kister J, Arous N, Bohn B, Loutradi A, Tsitrakis G, Poyart C. He­moglobin Koln occurring in association with a b⁰ thalas­semia: hematologic and functional consequences. Blood 1989; 74: 496-500.

13. Wajcman H, Byckova V, Haidas S, Labie D. Con­sequences of heme loss in unstable hemoglobins. A study of Hemoglobin Köln. FEBS Lett 1971; 13: 145-148.

14. Codrington JF, Kutlar F, Harris HF, Wilson JB, Stoming TA, Huisman THJ Hb A₂-Wrens or a₂d₂98(FG5) Val®Met, an unstable d chain variant identified by se­quence analysis of amplified DNA. Biochim Biophys Acta 1989; 1009: 87-89.

15. Coleman MB, Lu Z-H, Smith CM II, Adams JG III, Harrell A, Pionczynski M, Steinberg MH. Two mis­sense mutations in the b-globin gene can cause severe b-thalassemia: Hemoglobin Medicine Lake [b32[B14]Leu­cine®Glutamine; b98[FG5]Valine®Methionine). J Clin Invest 1995; 95: 503-509.

16. Nute PE, Stamatoyannopoulos G. Cases of abnor­mal human hemoglobin produced by de novo mutation. Hemoglobin 1988; 12(4): 429-439.

17. Tuohy AM, McKie VC, Sabio H, Kutlar F, Kutlar A, Wilson JB. Hb Hammersmith [b42(CD1)Phe®Ser]: occurrence as a de novo mutation in Black monozygotic twins with multiple congenital anomalies. J Pediatr Hema­tol Oncol 1998; 20 :563-566.

18. Wajcman H, Girodon E, Promé D, North ML, Plassa F, Duwig I, Kister J, Bergerat JP, Oberling F, Lampert E, Lonsdorfer J, Goossens M, Galacteros F. Germline mosaicism for an alanine to valine substitution at residue b140 in Hemoglobin Puttelange, a new variant with high oxygen affinity. Hum Genet 1995; 96: 711-716.

19. Cunningham TA, Baker F, Kobrinsky NL, Cepre­ganova B, Baysal E, Wilson JB, Huisman THJ. The unsta­ble Hb Hammersmith or a₂b₂(42)(CD1)Phe®Ser observed in an Indian child: identification by HPLC and by se­quence analysis of amplified DNA. Hemoglobin 1992; 16(1&2): 19-25.

20. Dianzani I, Ramus S, Cotton RG, Camaschella C. 1991; A spontaneous mutation causing unstable Hb Ham­mersmith: detection of the b42 TTT®TCT change by CCM and direct sequencing. Br J Haematol 1991; 79: 127-129.

21. Rahbar S, Bennetts GA, Ettinger LJ. Hemoglobin Hammersmith as the cause of severe hemolytic anemia in a Chinese girl. Am J Pediatr Hematol Oncol 1986; 8: 13-17.

22. Wajcman H, Leroux A, Labie D. Functional prop­erties of Hemoglobin Hammersmith. Biochimie 1973; 55: 119-125

23. Wajcman H, Krishnamoorthy R, Gacon G, Elion J, Allard C, Labie D. A new hemoglobin variant involving the distal histidine: Hb Bicźtre (b63(E7)His®Pro). J Mol Med 1976; 1: 187-197

24. Miller DR, Wilson JB, Kutlar A, Huisman THJ. Hb Bicźtre or a₂b₂63(E7)His®Pro in a Caucasian male: clinical observations over a period of 25 years. Am J Hematol 1986; 21: 209-214.

25. Wajcman H, Blouquit Y, Vasseur C, LeQuerrec A, Laniece M, Melevendi C, Rasore A, Galacteros F. Two new human hemoglobin variants due to rare mutational events : Hb Zaļre that contains a five residue repetition within the a-chain and Hb Duino that has two residues substituted in the b-chain. Hum Genet 1992; 89: 676-680.

26. Giacometti GM, Brunori M, Antonini E, Di Iorio EE, Winterhalter KH. The reaction of Hemoglobin Zurich with oxygen and carbon monoxide. J Biol Chem. 1980; 255: 6160-6165.

27. Milner PF, Corley CC, Pomeroy WL, Wilson JB, Gravely M, Huisman THJ. Thalassemia intermedia caused by heterozygosity for both b-thalassemia and Hemoglobin Saki [b14(A11)Leu®Pro]. Am J Hematol 1976; 1: 283-292.

28. Beuzard Y, Basset P, Braconnier F, el Gammal H, Martin L, Oudard JL, Thillet J, Caburi J. Haemoglobin Saki a₂b₂14 Leu®Pro(A11) structure and function. Bio­chim Biophys Acta 1975; 393: 182-187.

29. Thein SL, Hesketh C, Taylor P, Temperley IJ, Hutchinson RM, Old JM, Wood WG, Clegg JB, Weath­erall DJ. Molecular basis for dominantly inherited inclu­sion body b-thalassemia. Proc Natl Acad Sci USA 1990; 87: 3924-3928.

30. Thein SL. Structural variants with a b-thalassemia phenotype. In: Disorders of Hemoglobin: Genetics, Patho­physiology, and Clinical Management. Steinberg MH, Forget BG, Higgs DR, Nagel RL (eds). Cambrige Univer­sity Press, Cambridge, UK, 2001; 342-355.

31. Gurgey A, Altay C, Gu L-H, Leonova JYe, Deli­balta A, Oner C, Huisman THJ. (1995) Hb Hakkari or a₂b₂31(B13)Leu®Arg, a severely unstable hemoglobin variant associated with numerous intra-erythroblastic in­clusions and erythroid hyperplasia of the bone marrow. Hemoglobin 1995; 19(3&4): 165-172.

32. Murru S, Poddie D, Sciarratta GV, Agosti S, Baffico M, Melevendi C, Pirastu M, Cao A. A novel b-globin structural mutant, Hb Brescia (b114 Leu®Pro), causing a severe b-thalassemia intermedia phenotype. Hum Mutat 1992; 1: 124-128.

33. Podda A, Galanello R, Maccioni L, Melis MA, Rosatelli C, Perseu L, Cao A. Hemoglobin Cagliari (b60 [E4]Val®Glu): a novel unstable thalassemic hemoglobin­opathy. Blood 1991; 77: 371-375.

34. Van Weel M, Harteveld CL, Bernini LF, Brouwers TM, Giordano PC. The second case of dominant b-thalassemia induced by the codon 127 (CAG®TAG) described as a de novo mutation in a Dutch boy. Hemo­globin 1999; 23(4): 389-393.

35. Lacerra G, Testa R, De Angioletti M, Schilirņ G, Carestia C. Hb Bronte or a93(FG5)Val®Gly: a new un­stable variant of the a2-globin gene, associated with a mild a⁺-thalassemia phenotype. Hemoglobin 2003; 27(3): 149-159.

36. Cepreganova B, Wilson JB, Huisman THJ, Hume HA. Hb Nottingham or a₂b₂98(FG5)Val®Gly observed as a de novo mutation in a Canadian child. Hemoglobin 1992; 16(1&2): 77-79.

37. Préhu C, Groff P, Kalmes G, Golinska B, Riou J, Promé D, Richelme-David S, Kiger L, Ducrocq R, Wajcman H. Short insertion in a hemoglobin chain: Hb Esch, an unstable a1 variant with duplication of the se­quence (-Ala⁶⁵-Leu-Thr-Asn⁶⁸-). Blood Cells Mol Dis 2003; (in press).

38. Ben-Bassat I, Simjanovska L, Jaber L, Efremov GD. Hb Taybe: description of genetics and laboratory findings in an Israeli Arab family. Hemoglobin 1998; 22(2): 161-166.

39. Pobedimskaya DD, Molchanova TP, Streichman S, Huisman THJ. Compound heterozygosity for two a-globin gene defects, Hb Taybe (a1; 38 or 39 minus Thr) and a poly A mutation (a2; AATAAA®AATAAG), re­sults in a severe hemolytic anemia. Am J Hematol 1994; 47(3): 198-202.

40. Galacteros F, Girodon E, M'Rad A, Martin J, Goossens M, Jaber L, Cohen IJ, Tamary H, Goshen Y, Zaizov R. Hb Taybe (a38 or 39 THR deleted): an a-glo­bin defect, silent in the heterozygous state and producing severe hemolytic anemia in the homozygous. C R Acad Sci III 1994; 317: 437-444.

41. Morle F, Francina A, Ducrocq R, Wajcman H, Gonnet C, Philippe N, Souillet G, Godet J. A new a chain variant Hb Sallanches [a2 104(G11) Cys®Tyr] associated with Hb H disease in one homozygous patient. Br J Haematol 1995; 91: 608-611.

42. Waye JS, Walker L, Chui DHK, Lafferty J, Kirby M. Homozygous Hb Sallanches [a104(G11)Cys®Tyr] in a Pakistani child with Hb H disease. Hemoglobin 2000; 24(4): 355-357.

43. Khan SN, Butt FI, Riazuddin S, Galanello R. Hb Sallanches [a104(G11)Cys®Tyr]: a rare a2-globin chain variant found in the homozygous state in three members of a Pakistani family. Hemoglobin 2000; 24(1): 31-35.

44. McBride KL, Snow K, Kubik KS, Fairbanks VF, Hoyer JD, Fairweather RB, Chaffee S, Edwards WH. Hb Dartmouth [a66(E15)Leu®Pro (a2) (CTG®CCG)]: a novel a2-globin gene mutation associated with severe neonatal anemia when inherited in trans with Southeast Asian a-thalassemia-1. Hemoglobin 2001; 25(4): 375-382.

45. Wajcman H, Vasseur C, Blouquit Y, Rosa J, Labie D, Najman A, Reman O, Leporrier M, Galacteros F. Un­stable a-chain hemoglobin variants with factitious b-thal­assemia biosynthetic ratio: Hb Questembert (a131[H14] Ser®Pro) and Hb Caen (a132[H15]Val®Gly). Am J Hematol 1993; 42: 367-374.

46.-Rochette J, Barnetson R, Thein SL, Varet B, Valensi F. Hb Questembert is due to a base substitution (T®C) in codon 131 of the a2-globin gene and has an a-thalassemia biosynthetic ratio. Am J Hematol 1995; 48: 289-290.

47. Adams JG III, Winter WP, Rucknagel DL, Spencer HH. Biosynthesis of Hemoglobin Ann Arbor: evidence for catabolic and feedback regulation. Science 1972; 176: 1427-1429.

48. Prehu C, Francina A, Behnken LJ, Prome D, Galacteros F, Wajcman H. An identical mutation carried by different genes: Hb Frankfurt [a50(CE8)His®Gln]. Haematologica 2003; 88: ECR19.